Literature DB >> 26863296

Laparoscopic Subxiphoid Hernia Repair with Intracorporeal Suturing of Mesh to the Diaphragm as a Means to Decrease Recurrence.

Omar M Ghanem1, Hamid R Zahiri2, Stephen Devlin2, Udai Sibia2, Adrian Park2, Igor Belyansky2.   

Abstract

BACKGROUND: Subxiphoid hernias are a rare complication of median sternotomy with an incidence of 1%-4.2%. Repair of subxiphoid hernias is technically demanding with recurrence rates of 42% and 30% following open and laparoscopic repairs, respectively. We present a novel approach to the laparoscopic repair of subxiphoid hernias with improved overlap and fixation.
MATERIALS AND METHODS: A novel technique for repairing subxiphoid hernias is described. The falciform ligament is dissected superiorly toward the diaphragm to allow proper subfascial positioning of the mesh with adequate overlap. Multiple nonabsorbable intracorporeal sutures are used to anchor the mesh to the diaphragm above the costal margins. Transfascial nonabsorbable sutures and tacks are used to fix the mesh to the anterior abdominal wall below the costal margin.
RESULTS: We have used this method in 4 patients with a mean age of 60.5 years and a female to male ratio of 4:0. The average hernia defect size was 20.5 cm(2), and the average duration of operation was 93 minutes. There were no reported postoperative complications or evidence of recurrence at the 1-year follow-up.
CONCLUSIONS: Laparoscopic repair of subxiphoid hernias can be safely accomplished with mesh sutured to the diaphragm for improved overlap and fixation with the goal of reducing recurrence rates.

Entities:  

Mesh:

Year:  2016        PMID: 26863296     DOI: 10.1089/lap.2015.0518

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  1 in total

1.  A comparison of laparoscopic and open repair of subxiphoid incisional hernias.

Authors:  J Raakow; J Schulte-Mäter; Y Callister; M Aydin; C Denecke; J Pratschke; M Kilian
Journal:  Hernia       Date:  2018-08-29       Impact factor: 4.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.